1. Home
  2. TVTX vs DFH Comparison

TVTX vs DFH Comparison

Compare TVTX & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • DFH
  • Stock Information
  • Founded
  • TVTX 2008
  • DFH 2008
  • Country
  • TVTX United States
  • DFH United States
  • Employees
  • TVTX N/A
  • DFH N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • DFH Homebuilding
  • Sector
  • TVTX Health Care
  • DFH Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • DFH Nasdaq
  • Market Cap
  • TVTX 2.5B
  • DFH 2.2B
  • IPO Year
  • TVTX N/A
  • DFH 2021
  • Fundamental
  • Price
  • TVTX $29.05
  • DFH $23.39
  • Analyst Decision
  • TVTX Strong Buy
  • DFH Hold
  • Analyst Count
  • TVTX 15
  • DFH 1
  • Target Price
  • TVTX $34.86
  • DFH $26.00
  • AVG Volume (30 Days)
  • TVTX 1.8M
  • DFH 292.4K
  • Earning Date
  • TVTX 10-30-2025
  • DFH 10-31-2025
  • Dividend Yield
  • TVTX N/A
  • DFH N/A
  • EPS Growth
  • TVTX N/A
  • DFH 0.34
  • EPS
  • TVTX N/A
  • DFH 3.08
  • Revenue
  • TVTX $333,865,000.00
  • DFH $4,708,435,000.00
  • Revenue This Year
  • TVTX $83.23
  • DFH $6.07
  • Revenue Next Year
  • TVTX $41.49
  • DFH $1.25
  • P/E Ratio
  • TVTX N/A
  • DFH $7.54
  • Revenue Growth
  • TVTX 87.94
  • DFH 20.19
  • 52 Week Low
  • TVTX $12.91
  • DFH $19.65
  • 52 Week High
  • TVTX $28.85
  • DFH $34.43
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 73.62
  • DFH 39.21
  • Support Level
  • TVTX $26.79
  • DFH $22.80
  • Resistance Level
  • TVTX $28.24
  • DFH $23.80
  • Average True Range (ATR)
  • TVTX 1.02
  • DFH 0.84
  • MACD
  • TVTX -0.01
  • DFH 0.03
  • Stochastic Oscillator
  • TVTX 100.00
  • DFH 43.83

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About DFH Dream Finders Homes Inc.

Dream Finders Homes Inc is engaged in the home building business. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the majority of its revenue from the Midwest segment.

Share on Social Networks: